Drug Type Antibody |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Dren Bio, Inc.Startup |
Active Organization Dren Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | Dren Bio, Inc.Startup | 02 Jun 2022 |
Endocrinology and Metabolic Disease | Discovery | - | Dren Bio, Inc.Startup | 02 Jun 2022 |
Fibrosis | Discovery | - | Dren Bio, Inc.Startup | 02 Jun 2022 |
Immune System Diseases | Discovery | - | Dren Bio, Inc.Startup | 02 Jun 2022 |
Musculoskeletal Diseases | Discovery | - | Dren Bio, Inc.Startup | 02 Jun 2022 |
Neoplasms | Discovery | - | Dren Bio, Inc.Startup | 02 Jun 2022 |
Respiratory Diseases | Discovery | - | Dren Bio, Inc.Startup | 02 Jun 2022 |